WallStreetZenWallStreetZen

NASDAQ: CGC
Canopy Growth Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CGC stock forecasts and price targets.

Forecast return on equity

Is CGC forecast to generate an efficient return?

Company
-8.63%
Industry
281.61%
Market
228.76%
CGC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CGC forecast to generate an efficient return on assets?

Company
-5.94%
Industry
154.79%
CGC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CGC earnings per share forecast

What is CGC's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.29
Avg 2 year Forecast
-$0.12
Avg 3 year Forecast
-$0.13

CGC revenue forecast

What is CGC's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$287.3M+42.28%
Avg 2 year Forecast
$308.3M+52.72%
Avg 3 year Forecast
$629.9M+212%
CGC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CGC revenue growth forecast

How is CGC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
41.09%
Industry
136.41%
Market
25.81%
CGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CGC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CGC$1.40N/AN/A
BIOA$13.21$13.50+2.20%Buy
SIGA$6.23N/AN/A
ETON$16.55N/AN/A
EOLS$6.81$19.75+190.01%Buy
View Top Pharmaceutical Stocks

Canopy Growth Stock Forecast FAQ

What is CGC's earnings growth forecast for 2026-2028?

(NASDAQ: CGC) Canopy Growth's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 374.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.58%.

Canopy Growth's earnings in 2025 is -$275,607,142.On average, 6 Wall Street analysts forecast CGC's earnings for 2026 to be -$99,476,364, with the lowest CGC earnings forecast at -$144,201,376, and the highest CGC earnings forecast at -$50,302,806. On average, 6 Wall Street analysts forecast CGC's earnings for 2027 to be -$41,884,785, with the lowest CGC earnings forecast at -$103,959,131, and the highest CGC earnings forecast at $25,151,403.

In 2028, CGC is forecast to generate -$45,375,184 in earnings, with the lowest earnings forecast at -$43,595,765 and the highest earnings forecast at -$46,709,748.

If you're new to stock investing, here's how to buy Canopy Growth stock.

What is CGC's revenue growth forecast for 2026-2028?

(NASDAQ: CGC) Canopy Growth's forecast annual revenue growth rate of 41.09% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 136.41%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.81%.

Canopy Growth's revenue in 2025 is $199,006,428.On average, 7 Wall Street analysts forecast CGC's revenue for 2026 to be $98,295,788,361, with the lowest CGC revenue forecast at $92,824,075,025, and the highest CGC revenue forecast at $102,583,503,690. On average, 6 Wall Street analysts forecast CGC's revenue for 2027 to be $105,505,857,154, with the lowest CGC revenue forecast at $99,264,202,916, and the highest CGC revenue forecast at $113,567,993,877.

In 2028, CGC is forecast to generate $215,545,810,725 in revenue, with the lowest revenue forecast at $106,272,376,095 and the highest revenue forecast at $329,907,699,220.

What is CGC's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: CGC) forecast ROA is -5.94%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 154.79%.

What is CGC's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CGC) Canopy Growth's current Earnings Per Share (EPS) is -$2.01. On average, analysts forecast that CGC's EPS will be -$0.29 for 2026, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at -$0.15. On average, analysts forecast that CGC's EPS will be -$0.12 for 2027, with the lowest EPS forecast at -$0.30, and the highest EPS forecast at $0.07. In 2028, CGC's EPS is forecast to hit -$0.13 (min: -$0.13, max: -$0.14).

What is CGC's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: CGC) forecast ROE is -8.63%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.